Boehringer Ingelheim and Lilly initiate first ever study to assess Jardiance® in people hospitalized for acute heart failure who have been stabilized - PRNewswire
[unable to retrieve full-text content] NAVIGATING THE SILENCE: RECONSIDERING TREATMENT PARADIGMS IN ASYMPTOMATIC SEVERE AORTIC STENOSIS ScienceDirect.com
Comments
Post a Comment